Back to main

Leon Cooperman's First Quarter Increases

Posted
5/24/2013 6:25:00 PM
By: GuruFocus
Referenced Stocks:C;CIM;EMN;MRK;NCT

Leon Cooperman 's current portfolio contains 81 stocks valued at over $6.5 billion. Leon Cooperman increased his holdings in 31 stocks in the most recent quarter; the following five companies represent Cooperman's five largest increases of the quarter. Newcastle Investment Corporation ( NCT )

Leon Cooperman increased his holdings in Newcastle Investment by 1254.27% during the first quarter. Cooperman bought 3,762,800 shares at an average price of $4.97 per share. Since his most recent increase the price per share of Newcastle has increased 6.2% from the average purchase price. Cooperman now holds on to 4,062,800 shares of Newcastle, representing 0.7% of his total portfolio.



Click here for the Holding History of other gurus

Newcastle Investment has a market cap of $1.32 billion; its shares were traded at around $5.25 with a P/E ratio of 2.40 and a P/S ratio of 2.00. The dividend yield of Newcastle is 16.40%.

Newcastle Investment Corp. is a real estate investment and finance company. Newcastle invests in, and actively manages, a portfolio of real estate related assets. It emphasizes on portfolio management, asset quality, liquidity, diversification, match funded financing and credit risk management.

Merck & Co Inc. ( MRK )

In the first quarter Cooperman increased his holdings in Merck & Co 225.64% by purchasing an additional 1,331,300 shares. He purchased the shares for an average price of $42.84 per share. Since his buy, the price per share has increased 9.3% from the average purchase price. Cooperman owns 1,921,300 shares of Merck & Co. These holdings make up 1.3% of Cooperman's total portfolio.



Click here for the Holding History of other gurus

Merck & Co. has a market cap of $139.53 billion; its shares were traded at around $46.82 with a P/E ratio of 23.90 and P/S ratio of 3.10. The dividend yield of Merck & Co stocks is 3.60%. The company had an annual average earnings growth of 1.8% over the past 10 years.

Merck is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. The company's operations are principally managed on a products basis and are comprised of four operating segments: Pharmaceutical, Animal Health, Consumer Care and Alliances.

Citigroup ( C )

Cooperman purchased 1,333,100 shares of Citigroup in the first quarter, increasing his stake in the company by 146.66%. He purchased the shares at an average price of $43.48 per share. Since his buy the price per share of Citigroup has increased 15.4%. Cooperman is currently holding on to 2,242,100 shares of Citigroup. These holdings make up 1.5% of Cooperman's current portfolio.



Click here for the Holding History of other gurus

Citigroup has a market cap of $154.57 billion; its shares were traded at around $50.33 with a P/E ratio of 17.60 and P/S ratio of 2.10. The dividend yield of Citigroup stocks is 0.10%.

Citigroup is a global financial services holding company, whose businesses provide consumers, corporations, governments and institutions with a range of financial products and services, including consumer banking, credit cards, corporate and investment banking, securities brokerage and wealth management. Citigroup has more than 200 million customer accounts and does business in more than 160 countries.

Chimera Investment Corporation ( CIM )

Cooperman increased his holdings in Chimera Investment 121.5% during the first quarter. The guru purchased 26,771,616 shares at an average price of $3.02 per share. Since his buy the price per share has increased 5.6% to around $3.19 per share.



As of the first quarter, Cooperman holds on to 48,805,196 shares of Chimera Investment. His holdings in the company equal 2.4% of his total portfolio.

Click here for the Holding History of other gurus

Chimera Investment has a market cap of $3.23 billion; its shares were traded at around $3.19 with a P/E ratio of 24.50. The dividend yield of Chimera Investments is 11.30%.

Chimera operates as a specialty finance company that invests in residential mortgage backed securities, residential mortgage loans, real estate-related securities and various other asset classes. The company's objective is to provide attractive risk-adjusted returns to its investors over the long-term, mainly through dividends and secondarily through capital appreciation. It intends to achieve this through investing in a class of financial assets to construct an investment portfolio that is designed to achieve attractive risk-adjusted returns and that is structured to comply with the various federal income tax requirements for REIT status.

Eastman Chemical Company ( EMN )

During the first quarter Cooperman increased his holdings in Eastman Chemical by 94.31%. Cooperman bought 748,600 shares at an average price of $59.92 per share. Since this buy the price per share has increased 1%. Cooperman now holds on to 1,542,400 shares, making up 1.7% of his total portfolio.



Click here for the Holding History of other gurus

Eastman Chemical Company has a market cap of $11.21 billion; its shares were traded at around $72.07 with a P/E ratio of 21.50 and a P/S ratio of 1.30. The dividend yield of Eastman stocks is 1.60%. The company had an annual average earnings growth of 19.6% over the past ten years. GuruFocus rated Eastman Chemical the business predictability rank of 2.5-star.

Eastman Chemical Company is a global chemical company which manufactures and sells a portfolio of chemicals, plastics and fibers. The company's products and operations are managed in five operating segments: the Coatings, Adhesives, Specialty Polymers, and Inks 'CASPI' segment; the Fibers segment, the Performance Chemicals and Intermediates 'PCI' segment, the Performance Polymers segment and Specialty Plastics 'SP' segment.

You can view Leon Cooperman's complete portfolio here. Also check out his Undervalued Stocks, High Yielding Stocks and Top Growth Companies.About GuruFocus: GuruFocus.com tracks the stocks picks and portfolio holdings of the world's best investors. This value investing site offers stock screeners and valuation tools. And publishes daily articles tracking the latest moves of the world's best investors. GuruFocus also provides promising stock ideas in 3 monthly newsletters sent to Premium Members .